Phase I/II Study of αPD1-MSLN-CAR T Cells in MSLN-positive Advanced Solid Tumors

Study Summary

An open, multicenter, phase I/II study to evaluate the safety, tolerability, and effectiveness of αPD1-MSLN-CAR T cells in patients With MSLN-positive advanced solid tumors

Interventions

Study Locations

Facility	City	State	Country
National Cancer Center Cancer Hospital Chinese Academy of Medical Sciences	Beijing		China

Official Trial Information

View on ClinicalTrials.gov